Anebulo Pharmaceuticals

About:

Anebulo is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.

Website: https://www.anebulo.com

Twitter/X: AnebuloP

Top Investors: National Institute on Drug Abuse (NIDA), Merida Capital Holdings, 22NW, LP

Description:

Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Its lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well-tolerated, and leads to weight loss, an effect that is consistent with central cannabinoid receptor type 1 antagonism.